Scalper1 News
Biotech advances, new investments and merger activity have helped lift drugmakers like Alexion Pharmaceuticals (ALXN), Celgene (CELG) and Biogen Idec (BIIB) past the rest of the market, which has seen some ups and downs recently. Those companies as well as Perrigo (PRGO) and Actavis (ACT) are all on IBD’s Big Cap Screen of the Day, which features large stocks with strong earnings and price performance. Several also appear in IBD’s Leaderboard, a Scalper1 News
Scalper1 News